Core Viewpoint - IMCD N.V. is set to hold its Annual General Meeting of Shareholders (AGM) on April 30, 2026, in Rotterdam, focusing on its role as a leading distributor of specialty chemicals and ingredients [1][2]. Company Overview - IMCD is a global leader in the distribution and formulation of specialty chemicals and ingredients, emphasizing sustainable value in the supply chain [2]. - The company employs over 5,200 individuals and reported revenues of EUR 4,779 million in 2025 [3]. AGM Details - The AGM will take place in person at the company's offices in Rotterdam, and shareholders are encouraged to check the company's website for updates regarding the meeting [1][2]. - Documentation related to the AGM is available in the Investors' section of IMCD's website [2]. Market Position - IMCD's shares are traded on Euronext Amsterdam under the symbol IMCD and are included in the Dutch ESG AEX index, recognized for best ESG practices among 25 companies [3].

NAME OF THE LAYOUT Winning together as a team Investor presentation March 2026 IMCD is a leading partner in specialty chemicals and ingredients distribution 5,246 €4,779 Revenue (in € M) >60 Countries 8 Business Groups 71k+ Customers Market-focused Technical Centres IMAGE WITH GRADIENT Professionals 1995 - IMCD founded in Rotterdam, Netherlands 2001 – Transition to single IT platform 2011 - IMCD surpasses €1 billion in annual revenue and expands to APAC 2013 - Expansion into Latin America with acquisitions ...

Core Viewpoint - IMCD N.V. has nominated Ruud Joosten to join its Supervisory Board as part of its long-term succession planning, with the proposal to be approved at the upcoming Annual General Meeting on April 30, 2026 [3][4]. Group 1: Company Overview - IMCD is a global leader in the distribution and formulation of specialty chemicals and ingredients, based in Rotterdam, the Netherlands [5]. - The company emphasizes sustainable value in the supply chain and aims to address future business challenges with a focus on partnership and transparency [5]. - In 2025, IMCD reported revenues of EUR 4,779 million and employed over 5,200 staff [6]. Group 2: Leadership and Board Composition - Ruud Joosten has been the CEO of Royal BAM Group NV since 2020 and has held various management roles at AkzoNobel, including COO from 2017 to 2020 [2]. - The Supervisory Board aims to expand its composition to include a sixth member, highlighting the importance of succession planning [3]. - Janus Smalbraak, Chair of the Supervisory Board, praised Joosten's extensive experience in the specialty distribution and chemical industry as a valuable addition to the board [4].

Core Insights - IMCD N.V. released its 2025 Annual Report, providing stakeholders with a comprehensive view of the company's performance in 2025 [1] - The company reported revenues of EUR 4,779 million in 2025, with over 5,200 employees [4] - IMCD is recognized for its commitment to ESG practices, being included in the Dutch ESG AEX index [4] Financial Calendar - Annual report for 2025 released on 4 March 2026 [2] - Upcoming financial events include the first three months 2026 results on 30 April 2026 and the Annual General Meeting on the same date [2] - Dividend-related dates include the ex-dividend date on 5 May 2026, record date on 6 May 2026, and payment date on 8 May 2026 [2] Company Overview - IMCD is based in Rotterdam, The Netherlands, and specializes in the distribution and formulation of specialty chemicals and ingredients [3] - The company emphasizes sustainable value in the supply chain and aims to address future business challenges with a focus on partnership and transparency [3]

Core Viewpoint - IMCD N.V. has nominated Andreas Igerl as Chief Commercial Officer (CCO) and member of the Management Board, aiming to enhance commercial excellence and strengthen supplier relationships [1][4]. Group 1: Appointment Details - Andreas Igerl will bring international experience to the Management Board and will continue to lead the EMEA region and Industrial Business Groups [2]. - The proposal for Igerl's appointment will be presented for approval at the Annual General Meeting on 30 April 2026, which will increase the Management Board to three members [4]. Group 2: Background of Andreas Igerl - Andreas Igerl, born in 1980, joined IMCD in 2019 and has held various leadership roles, including President of IMCD EMEA and Industrial Business Groups [3]. - He has prior experience as President for IMCD Asia-Pacific and Managing Director for IMCD China, and holds a master's degree in business administration [3]. Group 3: Company Overview - IMCD, headquartered in Rotterdam, is a leading global partner in the distribution and formulation of specialty chemicals and ingredients, focusing on sustainable value in the supply chain [6]. - In 2025, IMCD reported revenues of EUR 4,779 million and employed over 5,200 people, with shares traded on Euronext Amsterdam [7].

Core Insights - IMCD N.V. reported its full-year 2025 results, highlighting both challenges and achievements in a difficult macroeconomic environment [1][2] Financial Performance - Revenue reached EUR 4,779 million, reflecting a 5% increase on a constant currency basis [5] - Gross profit was EUR 1,194 million, up 3% on a constant currency basis [5] - Operating EBITA decreased to EUR 498 million, down 3% on a constant currency basis [5] - Free cash flow increased by 3% to EUR 465 million, compared to EUR 450 million in 2024 [5] - Cash earnings per share were EUR 5.19, down from EUR 6.34 in 2024 [5] - A dividend proposal of EUR 1.81 in cash per share was made, down from EUR 2.15 in 2024 [5] Strategic Developments - The company completed seven strategic acquisitions in 2025, enhancing its offerings to customers and suppliers [3][5]

Company Overview - IMCD is a leading global partner for the distribution and formulation of specialty chemicals and ingredients, based in Rotterdam, The Netherlands [3] - The company emphasizes sustainable value addition to the supply chain and aims to address future business challenges with a focus on partnership and transparency [3] Financial Performance - In 2024, IMCD reported revenues of EUR 4,728 million, with over 5,100 employees [4] - IMCD N.V.'s shares are traded on Euronext Amsterdam and are included in the Dutch ESG AEX index, recognized for best ESG practices [4] Upcoming Events - IMCD will publish its Full Year results for 2025 on February 18, 2026, at 07:00 am CET [1] - Following the publication, an analyst conference call and webcast will be hosted by CEO Marcus Jordan and CFO Hans Kooijmans at 09:00 am CET [1] - The presentation will be available on the company's website under the Investor Relations section on the publication date [2]

Core Viewpoint - IMCD N.V. has nominated Floris Lagerwerf as the new Chief Financial Officer (CFO) effective January 2027, succeeding Hans Kooijmans who will retire at the end of December 2026 [1][3]. Group 1: Leadership Transition - Floris Lagerwerf has a strong background within IMCD, having joined the company in 2016 and held various finance roles, including Vice-President Finance & Operations for the Americas since January 2023 [2]. - The Supervisory Board expresses confidence in Floris's capabilities, highlighting his deep understanding of IMCD's business and proven track record in finance and M&A [3]. - Hans Kooijmans will continue to support Floris during the transition period until the end of 2026, emphasizing the importance of internal succession [4]. Group 2: Company Performance and Structure - IMCD reported revenues of EUR 4,728 million in 2024 and employs over 5,100 staff [6]. - The company is listed on Euronext Amsterdam and is part of the Dutch ESG AEX index, recognized for its best ESG practices [6].

Core Insights - IMCD N.V. reported a gross profit growth of 2% to EUR 927 million, with a 5% increase on a constant currency basis, indicating resilience in its financial performance despite challenging macro-economic conditions [3][5] - The company experienced a slight decline in operating EBITA, down 2% to EUR 394 million, but showed a 1% increase on a constant currency basis, reflecting stable operational efficiency [5] - Free cash flow for the first nine months was EUR 284 million, compared to EUR 299 million in the same period of 2024, suggesting a minor decrease in cash generation [5] - Cash earnings per share decreased to EUR 4.16 from EUR 4.67 in the first nine months of 2024, indicating a reduction in profitability per share [5] - IMCD expanded its market presence through six completed acquisitions and signed two additional transactions year to date, enhancing its footprint in key markets [5] Company Strategy - The CEO highlighted the company's focus on cost effectiveness and commercial excellence, which are crucial for navigating ongoing uncertainties in global trade and tariff discussions [3] - The company maintains confidence in its asset-light business model, which is supported by a diverse portfolio and advanced digital and supply chain capabilities [3]

Core Viewpoint - IMCD is set to release its First Nine Months 2025 results on November 6, 2025, at 07:00 am CET, followed by an analyst conference call and webcast at 09:00 am CET [1][2]. Company Overview - IMCD, headquartered in Rotterdam, The Netherlands, is a leading global partner in the distribution and formulation of specialty chemicals and ingredients [3]. - The company emphasizes sustainable value addition to the supply chain and aims to address future business challenges with a focus on partnership and transparency [3]. Financial Performance - In 2024, IMCD reported revenues of EUR 4,728 million and employed over 5,100 individuals [4]. - IMCD N.V.'s shares are traded on Euronext Amsterdam under the symbol IMCD and are included in the Dutch ESG AEX index, recognized for best ESG practices [4].